98 related articles for article (PubMed ID: 21784955)
21. Circulating soluble CD27 and CD30 in workers exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD).
Saberi Hosnijeh F; Portengen L; Bueno-de-Mesquita HB; Heederik D; Vermeulen R
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2420-4. PubMed ID: 24108789
[TBL] [Abstract][Full Text] [Related]
22. Soluble CD30 in normal pregnancy, pre-eclampsia and recurrent pregnancy loss.
Gharesi-Fard B; Jafarzadeh L; Zolghadri J; Haghbin H
Iran J Immunol; 2012 Dec; 9(4):234-40. PubMed ID: 23268289
[TBL] [Abstract][Full Text] [Related]
23. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation.
Fields RC; Bharat A; Steward N; Aloush A; Meyers BF; Trulock EP; Chapman WC; Patterson GA; Mohanakumar T
Transplantation; 2006 Dec; 82(12):1596-601. PubMed ID: 17198242
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation.
Hübel K; Cremer B; Heuser E; von Strandmann EP; Hallek M; Hansen HP
Transpl Immunol; 2010 Aug; 23(4):215-9. PubMed ID: 20620210
[TBL] [Abstract][Full Text] [Related]
25. High pretransplantation soluble CD30 levels: impact in renal transplantation.
Giannoli C; Bonnet MC; Perrat G; Houillon A; Reydet S; Pouteil-Noble C; Villar E; Lefrançois N; Morelon E; Dubois V
Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
[TBL] [Abstract][Full Text] [Related]
26. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition.
Saberi Hosnijeh F; Krop EJ; Scoccianti C; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Nawroly N; Portengen L; Linseisen J; Vineis P; Vermeulen R
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1577-84. PubMed ID: 20501772
[TBL] [Abstract][Full Text] [Related]
27. Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
Wu Q; Zhang J; Shi J; Ge M; Li X; Shao Y; Yao J; Zheng Y
PLoS One; 2014; 9(11):e110787. PubMed ID: 25383872
[TBL] [Abstract][Full Text] [Related]
28. Plasma soluble CD30 level correlates negatively with age in children.
Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
[TBL] [Abstract][Full Text] [Related]
29. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
Matinlauri I; Höckerstedt K; Isoniemi H
Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
[TBL] [Abstract][Full Text] [Related]
31. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.
Sengul S; Keven K; Gormez U; Kutlay S; Erturk S; Erbay B
Transplantation; 2006 Apr; 81(8):1216-9. PubMed ID: 16641611
[TBL] [Abstract][Full Text] [Related]
32. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease.
Mahmoudi MJ; Hedayat M; Rezaei N; Saboor-Yaraghi AA; Mahmoudi M
Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):237-42. PubMed ID: 22184265
[TBL] [Abstract][Full Text] [Related]
33. Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation.
Hamer R; Roche L; Smillie D; Harmer A; Mitchell D; Molostvov G; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Briggs D; Lowe D; Zehnder D; Higgins R
Transpl Immunol; 2010 Aug; 23(4):161-5. PubMed ID: 20600903
[TBL] [Abstract][Full Text] [Related]
34. Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
Pavlova Y; Viklicky O; Slatinska J; Bürgelova M; Süsal C; Skibova J; Honsová E; Striz I; Kolesar L; Slavcev A
Transpl Immunol; 2011 Jul; 25(1):72-6. PubMed ID: 21376809
[TBL] [Abstract][Full Text] [Related]
35. Level of soluble CD30 after kidney transplantation correlates with acute rejection episodes.
Yang JL; Hao HJ; Zhang B; Liu YX; Chen S; Na YQ
Transplant Proc; 2008 Dec; 40(10):3381-3. PubMed ID: 19100394
[TBL] [Abstract][Full Text] [Related]
36. CD30, a marker to detect the high-risk kidney transplant recipients.
Spiridon C; Nikaein A; Lerman M; Hunt J; Dickerman R; Mack M
Clin Transplant; 2008; 22(6):765-9. PubMed ID: 19040559
[TBL] [Abstract][Full Text] [Related]
37. Value of soluble CD30 in liver transplantation.
Fábrega E; Unzueta MG; Cobo M; Casafont F; Amado JA; Romero FP
Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
[TBL] [Abstract][Full Text] [Related]
38. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
[TBL] [Abstract][Full Text] [Related]
39. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
[TBL] [Abstract][Full Text] [Related]
40. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
